Long-term results of autologous peripheral blood hematopoietic stem cell transplantation in patients with peripheral arterial diseases

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The aim of our work was to assess long-term results of autologous peripheral blood hematopoietic stem cell application in patients with peripheral arterial diseases. Peripheral blood hematopoietic stem cells mobilized by granulocyte colony-stimulating factor were transplanted intramuscularly to 30 patients with peripheral arterial diseases (IIb stage by Pokrovsky). Standart tredmill test, ankle-brachial index estimation and ankle-brachial index restoration time estimation after loading were performed on 0, 3, 6, 12 and 60 months after transplantation. Immunohistochemical study of injured gastrocnemius muscle biopsies taken before peripheral blood hematopoietic stem cells transplantation and 3 months after the procedure was performed. Peripheral blood hematopoietic stem cells transplantation increases capillary density (22,4%, p = 0,0005). Ankle- brachial index increased by 18,1% on month 6 after transplantation without a tendency to change on month 12. 60 months after transplantation initial to hematopoietic stem cells transplantation ankle-brachial index rates were marked. Painless walking distance was increasing at all times of observation progressively, on month 60 no walking distance limitation was marked by most patients. Ankle-brachial index restoring time shows positive trend of the functional state of limb during the first year after transplantation, 60 months after transplantation it showed no «walking reserve» limitation in most patients. 5-years survival was 79%, death causes were stroke, cardiac pathology (3 cases), lung cancer. So, peripheral blood hematopoietic stem cells transplantation allows eliminating peripheral arterial diseases symptoms and preserving limb in long-term period. Autologous transplantation of peripheral blood hematopoietic stem cells has no complications and is safe for therapy of patients with peripheral arterial diseases II stage.

Full Text

Restricted Access

About the authors

M. V Plotnikov

Republic Clinical Hospital of Republic of Tatarstan; Kazan State Medical Academy

Kazan

A. V Maksimov

Republic Clinical Hospital of Republic of Tatarstan; Kazan State Medical Academy

Kazan

M. O Mavlikeev

Kazan Federal University

Kazan

I. M Gazizov

Kazan Federal University

Kazan

V. P Tamakova

Republic Clinical Hospital of Republic of Tatarstan

Kazan

G. V Cherepnev

Republic Clinical Hospital of Republic of Tatarstan

Kazan

I. I Shamsutdinova

Republic Clinical Hospital of Republic of Tatarstan

Kazan

A. A Gumerova

Kazan Federal University

Kazan

A. P Kiassov

Kazan Federal University

Kazan

References

  1. Савельев B.C., Кошкин В.М. Критическая ишемия нижних конечностей. М.: Медицина. 1997; 160 с.
  2. Aquino R., Johnnides Ch., Makaroun M. et al. Natural history of claudication: Long-term serial follow-up study of 1244 claudicants. J. Vasc. Surg. 2001; 34: 962-70.
  3. Norgren L., Hiatt W.R., Dormandy J.A. et al. Trans-Atlantic Inter-Society Consensus for the management of peripheral arterial disease (TASC II). J. Vasc. Surg. 2007; 45(Suppl): S5-67.
  4. The I.C.A.I. Group. Long-term mortality and its predictors in иммуногистохимических исследований. По всей видимости, это связано со стимуляцией ангиогенеза трансплантированными ГСК. Таким образом, введение ГСК позволяет купировать симптомы ЗПА и сохранить конечность в отдаленном периоде. Аутотрансплантацию ГСК, в виду отсутствия нежелательных явлений и осложнений на всех сроках наблюдения, можно считать безопасным методом лечения ЗПА у пациентов со II6 степенью ишемии. patients with critical leg ischemia. Eur. J. Vasc. Endovasc. Surg. 1997; 14(2): 91-5.
  5. Национальные рекомендации по ведению пациентов с сосудистой артериальной патологией. Часть 1. Периферические артерии. М., 2011; 175 c.
  6. Мавликеев М.О., Андреева Д.И., Газизов И.М. и др. Регенерация мышечной ткани и активация миосателлитоцитов при аутотрансплантации стволовых клеток периферической крови пациентам с хроническими облитерирующими заболеваниями артерий нижних конечностей. Клеточная трансплантология и тканевая инженерия 2010; V(4): 79-84.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2013 Eco-Vector



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: 

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies